HuGE Literature Finder
Records
1
-
3
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia. Blood cancer journal 2017 Apr 7 (4): e559. Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E, Hirase C, Takeshita A, Imai K, Okumura H, Morishita Y, Usui N, Takahashi N, Fujisawa S, Shiraishi Y, Chiba K, Tanaka H, Kiyoi H, Ohnishi K, Ohtake S, Asou N, Kobayashi Y, Miyazaki Y, Miyano S, Ogawa S, Matsumura I, Nakaseko C, Naoe |
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PloS one 2012 7 (8): e43090. Traina Fabiola, Visconte Valeria, Jankowska Anna M, Makishima Hideki, O'Keefe Christine L, Elson Paul, Han Yingchun, Hsieh Fred H, Sekeres Mikkael A, Mali Raghuveer Singh, Kalaycio Matt, Lichtin Alan E, Advani Anjali S, Duong Hien K, Copelan Edward, Kapur Reuben, Olalla Saad Sara T, Maciejewski Jaroslaw P, Tiu Ramon |
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood 2011 May 117 (21): e198-206. Makishima Hideki, Jankowska Anna M, McDevitt Michael A, O'Keefe Christine, Dujardin Simon, Cazzolli Heather, Przychodzen Bartlomiej, Prince Courtney, Nicoll John, Siddaiah Harish, Shaik Mohammed, Szpurka Hadrian, Hsi Eric, Advani Anjali, Paquette Ronald, Maciejewski Jaroslaw |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 09, 2022
- Content source: